- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fonar settles patent dispute with Elscint
MRI developer Fonar has announced that it has resolved its pending patent infringement litigation with Elscint. Terms of the agreement were not released.The deal adds another to the list of companies that have settled MRI patent disputes with Fonar.
MRI developer Fonar has announced that it has resolved its pending patent infringement litigation with Elscint. Terms of the agreement were not released.
The deal adds another to the list of companies that have settled MRI patent disputes with Fonar. Hitachi, Philips, Siemens, Toshiba, and Shimadzu have all reached settlements with them in recent years, while GE lost its legal battle with the firm in 1997, paying a total of $128.7 million (SCAN 7/9/97).
In other Fonar news, the Melville, NY-based company has appointed Sol Ginzburg as vice president of sales. He had recently served as director of international sales for the firm.
Fonar also announced that Pennsylvania Medical Group has acquired another of its Quad 12000 devices for an imaging center in Reading, PA. The group already employs a Quad 12000 scanner at an imaging facility in Philadelphia. Fonar valued the groups latest purchase at $1.2 million.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
